Voltron Therapeutics, Inc. is improving cell-mediated responses to combat infectious diseases, such as COVID-19 and specific forms of cancers, using the advanced and proprietary VaxCelerate™ Self-Assembling Vaccine Design developed by specialists at the Massachusetts General Hospital (MGH) and the Vaccine & Immunotherapy Center. Voltron has an exclusive license to this technology from MGH.

Stay tuned for more information as the website gets updated or contact us NOW.